Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Amgen Stake Reduced by 45.8% Amid Q2 Portfolio Adjustments

Guavy AI Editorial Team
Instruments
AMGN
Share

111 Capital has reduced its holdings in Amgen Inc. (NASDAQ:AMGN) by 45.8% during the second quarter, according to a recent Form 13F filing with the SEC.

The firm owned 3,851 shares of the medical research company's stock after selling 3,259 shares during the quarter.

As of its most recent SEC filing, 111 Capital's holdings in Amgen were worth $1,395,000.

This is not an isolated instance; other hedge funds and institutional investors have also made changes to their positions in Amgen during the second quarter.

More on Stocks

Stocks 2m ago

Nvidia Reveals What Makes Startups Stand Out for Corporate VC Partnerships

Stocks 2m ago

Nvidia Dominates AI Chip Market as Marvell Gains Ground

Stocks 3m ago

IBM Sees Shift in Customer Spending Priorities Amid Software Sales Shortfall

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy